These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2756360)
1. Tissue calcium in uraemia. Krog M; Ejerblad S; Johansson H; Pettersson L Scand J Urol Nephrol; 1989; 23(2):141-4. PubMed ID: 2756360 [TBL] [Abstract][Full Text] [Related]
2. The effect of vitamin D treatment on decreased levels of ATP and energy charge in the thoracic aorta of uraemic rats. Krog M; Ejerblad S; Johansson H; Ronquist G Br J Exp Pathol; 1989 Apr; 70(2):193-8. PubMed ID: 2730840 [TBL] [Abstract][Full Text] [Related]
3. Tissue calcification and alkaline phosphatase activity in uraemic rats. Krog M; Ejerblad S; Johansson H; Wilander E Scand J Urol Nephrol; 1988; 22(1):45-51. PubMed ID: 3387911 [TBL] [Abstract][Full Text] [Related]
4. Effect of 1,25-dihydroxyvitamin D3 and diltiazem on tissue calcium in uremic rat. Inagaki O; Nakagawa K; Syono T; Nishian Y; Takenaka Y; Takamitsu Y Ren Fail; 1995 Nov; 17(6):651-7. PubMed ID: 8771237 [TBL] [Abstract][Full Text] [Related]
5. The aortic content of glycosaminoglycans, hydroxyproline and calcium in experimental uraemia with special reference to parathyroidectomy and vitamin-D treatment. Krog M; Ejerblad S; Johansson H Scand J Urol Nephrol; 1984; 18(3):241-7. PubMed ID: 6494831 [TBL] [Abstract][Full Text] [Related]
6. Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy. Krog M; Ejerblad S; Eriksson I; Johansson H Scand J Urol Nephrol; 1984; 18(3):227-39. PubMed ID: 6494830 [TBL] [Abstract][Full Text] [Related]
7. Effects of thyroparathyroidectomy, phosphate depletion and diphosphonate therapy on acute uraemic extra-osseous calcification in the rat. Ibels LS; Alfrey AC Clin Sci (Lond); 1981 Nov; 61(5):621-6. PubMed ID: 6793280 [TBL] [Abstract][Full Text] [Related]
8. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797 [TBL] [Abstract][Full Text] [Related]
9. Effect of long-term administration of 1,25-dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 on the calcium content of the aorta, heart and kidney of normal and uremic rats. Saupe J; Hirschberg R; Höfer W; Bosaller W; von Herrath D; Pauls A; Schaefer K Nephron; 1986; 43(4):290-2. PubMed ID: 3755509 [TBL] [Abstract][Full Text] [Related]
11. Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. Goligorsky MS; Chaimovitz C; Rapoport J; Goldstein J; Kol R Kidney Int; 1985 May; 27(5):774-9. PubMed ID: 4021311 [TBL] [Abstract][Full Text] [Related]
12. Recombinant erythropoietin increases blood pressure in experimental hypertension and uraemia without change in vascular cytosolic calcium. Roger SD; Fluck RJ; McMahon AC; Raine AE Nephron; 1996; 73(2):212-8. PubMed ID: 8773347 [TBL] [Abstract][Full Text] [Related]
13. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding. Binswanger U; Schiffl H; Huggler M; Becker C Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642 [TBL] [Abstract][Full Text] [Related]
14. Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats. Kainer G; Nakano M; Massie FS; Foreman JW; Chan JC Pediatr Res; 1991 Dec; 30(6):528-33. PubMed ID: 1805148 [TBL] [Abstract][Full Text] [Related]
15. Effect of dihydroxylated metabolites of vitamin D3 on calcium absorption in uraemic man. Muirhead N; Catto GR; Gvozdanovic S; Gvozdanovic D; Edward N Clin Sci (Lond); 1981 Dec; 61(6):723-7. PubMed ID: 6975197 [TBL] [Abstract][Full Text] [Related]
16. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia. Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757 [TBL] [Abstract][Full Text] [Related]
17. Long-term 1,25-dihydroxycholecalciferol treatment in renal failure. Hortling L; Fyhrquist F; Bonsdorff MV; Holmberg P; Edgren J; Kock B; Tella M; Eklund B; Holmström T Acta Med Scand; 1983; 214(1):55-60. PubMed ID: 6353876 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Mizobuchi M; Finch JL; Martin DR; Slatopolsky E Kidney Int; 2007 Sep; 72(6):709-15. PubMed ID: 17597697 [TBL] [Abstract][Full Text] [Related]
19. Interaction between dietary 1,25-dihydroxycholecalciferol and calcium and effects of management on the occurrence of tibial dyschondroplasia, leg abnormalities and performance in broiler chickens. Rennie JS; McCormack HA; Farquharson C; Berry JL; Mawer EB; Whitehead CC Br Poult Sci; 1995 Jul; 36(3):465-77. PubMed ID: 7583377 [TBL] [Abstract][Full Text] [Related]
20. Reduction of vitamin D induced stone formation by calcium. Strohmaier WL; Seeger RD; Osswald H; Bichler KH Urol Res; 1994; 22(5):301-3. PubMed ID: 7879315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]